Company Filing History:
3 out of 1,036 
1 out of 549 
Years Active: 2006-2012
Title: The Innovative Contributions of Glenn M Swartz
Introduction
Glenn M Swartz is a notable inventor based in Mt. Airy, MD (US), recognized for his significant contributions to the field of pharmaceuticals. With a total of four patents to his name, Swartz has made strides in developing compounds that have the potential to treat serious medical conditions.
Latest Patents
Swartz's latest patents focus on the synthesis of 4-amino-thalidomide enantiomers. His inventions provide new and useful analogs of 4-amino-thalidomide, specifically S(−)-4-amino-thalidomide and R(+)-4-amino-thalidomide. These patents also detail processes for creating these analogs. Furthermore, they outline methods for inhibiting angiogenesis and treating angiogenesis-associated diseases, including cancer and macular degeneration, through the administration of these compounds.
Career Highlights
Throughout his career, Glenn M Swartz has worked with reputable organizations, including Children's Medical Center Corporation and Celgene Corporation. His work in these institutions has allowed him to contribute to advancements in medical research and drug development.
Collaborations
Swartz has collaborated with esteemed colleagues such as Robert J D'Amato and Jamshed H Shah. These partnerships have likely enhanced his research and innovation efforts in the pharmaceutical field.
Conclusion
Glenn M Swartz's innovative work in synthesizing 4-amino-thalidomide enantiomers showcases his commitment to advancing medical science. His contributions have the potential to impact the treatment of critical health issues, making him a significant figure in the realm of invention.